London & Capital Asset Management LTD Abbott Laboratories Transaction History

London & Capital Asset Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $320,281 - $388,958	-3,495 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $62,787 - $80,360	820 Added 30.65%	3,495 $320,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $609,102 - $890,674	-9,696 Reduced 78.38%	2,675 $211,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $6,594 - $7,341	84 Added 0.68%	12,371 $1.08 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $180,702 - $195,937	-2,208 Reduced 15.23%	12,287 $1.03 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $504,183 - $588,030	-6,918 Reduced 32.31%	14,495 $1.22 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $13 Million - $15.7 Million	-196,023 Reduced 90.15%	21,413 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $14.3 Million - $16.1 Million	217,436 New	217,436 $15.7 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on London & Capital Asset Management LTD with notifications on news.